Huntley, DixieGiménez, EstelaPascual, María JesúsVázquez, LourdesAmat, PaulaRemigia, María JoséHernández Martín, Marta MaríaHernández Boluda, Juan CarlosGago, BeatrizPiñana, José LuisGarcía, MagdalenaPérez, AriadnaAlberola, JuanGozalbo Rovira, RobertoAlbert, EliseoSolano, CarlosNavarro, David2024-07-312024-07-312020-05-23Huntley, D., Giménez, E., Pascual, M.J. et al. Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant 55, 1493–1496 (2020). https://doi.org/10.1038/s41409-020-0950-10268-33691476-536510.1038/s41409-020-0950-1https://hdl.handle.net/20.500.14352/107317grant from Carlos III Health Institute (15/0060)Cytomegalovirus (CMV) DNAemia remains a clinically relevant problem following allogeneic stem cell transplantation (allo-HSCT). Currently, enumeration of IFN-γ- producing CMV-specific T cells provides helpful yet improvable data for patient stratification for risk of primary or recurrent CMV DNAemia and for predicting clinically refractory episodes of CMV DNAemia.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/journal articlehttps://doi.org/10.1038/s41409-020-0950-1https://www.nature.com/bmt/metadata only access61Peripheral blood regulatory T cellsCytomegalovirus DNAemiaCiencias Biomédicas32 Ciencias Médicas